We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class A
GOOGL
$3.91T
| $853M | 3.42% |
14,141,140
+12,937,780
| +1,075% | +$783M |
|
|
2
Genuine Parts
GPC
$17B
| $594M | 2.38% |
5,979,845
+5,846,873
| +4,397% | +$573M |
|
|
3
Paychex
PAYX
$40.2B
| $468M | 1.88% |
6,357,793
+5,999,001
| +1,672% | +$431M |
|
|
4
Apple
AAPL
$4.9T
| $443M | 1.78% |
7,856,568
-1,473,396
| -16% | -$76.7M |
|
5
Microsoft
MSFT
$2.86T
| $399M | 1.6% |
3,490,766
-227,163
| -6% | -$24.6M |
|
6
Boeing
BA
$167B
| $293M | 1.17% |
787,933
-12,610
| -2% | -$4.43M |
|
7
Home Depot
HD
$330B
| $292M | 1.17% |
1,408,522
-52,424
| -4% | -$10.6M |
|
|
8
Johnson & Johnson
JNJ
$633B
| $281M | 1.13% |
2,036,984
-6,048,824
| -75% | -$804M |
|
9
Cisco
CSCO
$449B
| $228M | 0.91% |
4,688,365
-118,569
| -2% | -$5.33M |
|
10
Pfizer
PFE
$140B
| $227M | 0.91% |
5,436,091
+1,950,313
| +56% | +$75.1M |
|
11
PepsiCo
PEP
$186B
| $196M | 0.78% |
1,750,688
+582,102
| +50% | +$65.9M |
|
12
ExxonMobil
XOM
$649B
| $195M | 0.78% |
2,292,889
-44,347
| -2% | -$3.63M |
|
13
Mastercard
MA
$473B
| $195M | 0.78% |
874,620
-100,436
| -10% | -$21M |
|
14
Amgen
AMGN
$203B
| $186M | 0.74% |
895,634
-42,827
| -5% | -$8.44M |
|
15
PayPal
PYPL
$49.6B
| $183M | 0.73% |
2,081,323
-523,192
| -20% | -$46.1M |
|
16
Chevron
CVX
$387B
| $183M | 0.73% |
1,492,642
-39,550
| -3% | -$4.8M |
|
17
Walt Disney
DIS
$166B
| $182M | 0.73% |
1,556,812
+132,665
| +9% | +$14.8M |
|
18
Oracle
ORCL
$341B
| $177M | 0.71% |
3,426,935
-672,705
| -16% | -$32.7M |
|
19
JPMorgan Chase
JPM
$938B
| $174M | 0.7% |
1,544,054
-49,351
| -3% | -$5.6M |
|
20
UnitedHealth
UNH
$383B
| $173M | 0.69% |
648,553
-59,522
| -8% | -$15.5M |
|
21
Visa
V
$673B
| $170M | 0.68% |
1,130,961
-197,376
| -15% | -$28.1M |
|
|
VMW
22
DELISTED
VMware, Inc
VMW
| $168M | 0.67% |
1,076,698
-213,084
| -17% | -$32.6M |
|
23
Intel
INTC
$480B
| $167M | 0.67% |
3,525,069
-75,040
| -2% | -$3.65M |
|
24
Waters Corp
WAT
$37B
| $159M | 0.64% |
815,251
-35,427
| -4% | -$6.86M |
|
|
25
Northern Trust
NTRS
$22.3B
| $153M | 0.61% |
1,494,466
+939,075
| +169% | +$101M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.